Yahoo
BOSTON, June 30, 2025--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that updated results from the Phase 1/2 FRAME study conducted by The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were published online in Nature Medicine. The full manuscript, titled "Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial," was
Finnhub
Verastem, Inc. added to Russell 3000 Value Index...
Finnhub
Verastem, Inc. added to Russell 2500 Value Index...
Finnhub
Verastem, Inc. added to Russell Small Cap Comp Value Index...
Finnhub
Verastem, Inc. added to Russell 2000 Value Index...
Finnhub
Verastem, Inc. added to Russell Microcap Value Index...
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| K | -13.07% | $27.76B | +41.17% | 2.85% |
| UNH | -11.74% | $279.00B | -37.22% | 2.74% |
| VHC | -9.14% | $48.19M | +108.24% | 0.00% |
| NEXA | -8.75% | $659.55M | -36.15% | 0.00% |
| CNC | -7.91% | $16.81B | -49.40% | 0.00% |
| CBOE | -7.90% | $24.23B | +35.36% | 1.09% |
| HUSA | -7.61% | $19.66M | -19.53% | 0.00% |
| AGL | -6.55% | $989.35M | -60.10% | 0.00% |
| GFI | -6.19% | $21.56B | +57.55% | 2.31% |
| HUM | -5.69% | $29.42B | -32.81% | 1.46% |
| PRPO | -5.67% | $17.08M | +125.94% | 0.00% |
| NOC | -4.70% | $71.81B | +14.14% | 1.69% |
| AQB | -4.05% | $2.96M | -53.35% | 0.00% |
| VSTA | -3.89% | $344.07M | +39.29% | 0.00% |
| CYD | -3.89% | $890.68M | +164.07% | 3.83% |
| STG | -3.75% | $30.78M | -22.51% | 0.00% |
| DFDV | -3.74% | $300.56M | +2,130.16% | 0.00% |
| AU | -3.58% | $23.49B | +78.98% | 2.23% |
| ED | -3.34% | $36.00B | +12.64% | 3.34% |
| TDUP | -2.63% | $895.13M | +358.79% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -26.08% | $164.54M | 0.85% |
| TAIL | -25.78% | $99.63M | 0.59% |
| BTAL | -25.75% | $296.22M | 1.43% |
| IVOL | -12.57% | $347.03M | 1.02% |
| FXY | -10.28% | $816.38M | 0.4% |
| CLIP | -9.13% | $1.51B | 0.07% |
| FTSD | -8.70% | $231.81M | 0.25% |
| AGZD | -8.17% | $102.70M | 0.23% |
| FXE | -7.99% | $568.94M | 0.4% |
| UDN | -7.52% | $148.33M | 0.78% |
| CARY | -6.58% | $347.36M | 0.8% |
| UNG | -5.05% | $360.54M | 1.06% |
| SHYM | -4.73% | $357.13M | 0.35% |
| XONE | -4.53% | $625.28M | 0.03% |
| SCHO | -4.52% | $11.03B | 0.03% |
| ULST | -4.33% | $654.75M | 0.2% |
| BWX | -4.07% | $1.53B | 0.35% |
| SPTS | -3.94% | $5.80B | 0.03% |
| STOT | -3.53% | $254.07M | 0.45% |
| BSMW | -3.38% | $107.45M | 0.18% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 40.12% | $4.82B | 0.35% |
| IWC | 39.93% | $818.14M | 0.6% |
| GNOM | 39.56% | $44.57M | 0.5% |
| ARKG | 38.53% | $1.02B | 0.75% |
| REM | 38.17% | $555.68M | 0.48% |
| MORT | 37.40% | $306.90M | 0.42% |
| XPH | 37.34% | $147.96M | 0.35% |
| KBWD | 36.70% | $406.65M | 4.93% |
| IBB | 35.66% | $5.26B | 0.45% |
| IWM | 35.47% | $63.72B | 0.19% |
| VTWO | 35.45% | $12.52B | 0.07% |
| IWO | 35.28% | $11.60B | 0.24% |
| KJUL | 35.26% | $119.50M | 0.79% |
| PBE | 35.25% | $223.19M | 0.58% |
| SATO | 35.16% | $11.40M | 0.6% |
| RIET | 34.74% | $89.59M | 0.5% |
| KJAN | 34.39% | $287.30M | 0.79% |
| SCHA | 34.29% | $17.26B | 0.04% |
| KOMP | 34.20% | $2.29B | 0.2% |
| IWN | 34.19% | $10.96B | 0.24% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SCHR | -0.01% | $10.92B | 0.03% |
| XHLF | -0.04% | $1.73B | 0.03% |
| TYA | 0.13% | $152.69M | 0.15% |
| IBTI | -0.14% | $1.06B | 0.07% |
| STXT | -0.15% | $129.40M | 0.49% |
| IBDQ | 0.17% | $2.98B | 0.1% |
| FXB | 0.19% | $92.34M | 0.4% |
| FLGV | 0.19% | $1.03B | 0.09% |
| VGIT | 0.21% | $31.89B | 0.04% |
| TBLL | 0.22% | $2.13B | 0.08% |
| CANE | 0.23% | $10.37M | 0.29% |
| IGOV | -0.39% | $1.22B | 0.35% |
| PSQA | -0.65% | $35.44M | 0.2% |
| LGOV | 0.69% | $678.86M | 0.67% |
| BNO | 0.69% | $103.79M | 1% |
| BUXX | 0.69% | $315.18M | 0.25% |
| IBND | -0.73% | $384.31M | 0.5% |
| IEI | -0.74% | $15.48B | 0.15% |
| FTSM | -0.78% | $6.37B | 0.45% |
| IBTL | -0.81% | $381.01M | 0.07% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LTM | -0.03% | $12.63B | -95.46% | 2.42% |
| GRFS | -0.04% | $2.36B | +37.65% | 0.00% |
| CCRN | -0.07% | $429.13M | -3.89% | 0.00% |
| NEUE | -0.09% | $61.24M | +29.92% | 0.00% |
| CME | -0.10% | $99.39B | +40.68% | 3.86% |
| CMBM | -0.16% | $11.39M | -82.98% | 0.00% |
| DRD | 0.16% | $1.18B | +51.33% | 2.03% |
| CHT | 0.33% | $36.42B | +25.70% | 3.21% |
| IMAB | -0.36% | $180.77M | +52.67% | 0.00% |
| PRT | -0.36% | $49.39M | +3.31% | 10.74% |
| AEP | 0.38% | $55.16B | +17.93% | 3.54% |
| EXC | 0.41% | $43.33B | +23.58% | 3.62% |
| SO | -0.51% | $100.18B | +17.28% | 3.18% |
| UUU | 0.63% | $7.17M | +101.30% | 0.00% |
| OS | 0.71% | $4.68B | +32.90% | 0.00% |
| CNP | 0.75% | $23.35B | +17.94% | 2.36% |
| LRN | -0.82% | $5.99B | +100.06% | 0.00% |
| BBDO | 0.89% | $14.11B | +34.89% | 3.23% |
| HMY | -0.90% | $8.87B | +52.35% | 1.21% |
| MCK | -0.92% | $88.11B | +20.93% | 0.40% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NNOX | 39.61% | $339.85M | -24.50% | 0.00% |
| GBIO | 38.83% | $22.65M | -86.15% | 0.00% |
| SYRE | 38.72% | $935.48M | -39.83% | 0.00% |
| IMNM | 38.11% | $750.92M | -28.80% | 0.00% |
| WGO | 38.10% | $891.37M | -40.29% | 4.22% |
| ARR | 37.63% | $1.38B | -13.50% | 17.04% |
| MFA | 37.37% | $996.76M | -7.87% | 14.52% |
| BEAM | 37.20% | $2.00B | -15.33% | 0.00% |
| APGE | 37.01% | $2.64B | +18.19% | 0.00% |
| CGEM | 36.36% | $457.95M | -53.75% | 0.00% |
| CRBU | 36.05% | $127.42M | -14.38% | 0.00% |
| IVR | 36.00% | $530.18M | -13.83% | 18.93% |
| CRSP | 35.78% | $4.46B | -4.14% | 0.00% |
| FBRT | 35.77% | $914.99M | -12.69% | 12.93% |
| PGEN | 35.50% | $475.24M | +9.52% | 0.00% |
| RXRX | 35.44% | $2.12B | -29.12% | 0.00% |
| NLY | 35.03% | $11.69B | +1.95% | 13.91% |
| RITM | 34.72% | $6.19B | +9.67% | 8.53% |
| INMD | 34.57% | $1.06B | -12.99% | 0.00% |
| ARCT | 34.53% | $369.38M | -37.89% | 0.00% |
Current Value
$4.871 Year Return
Current Value
$4.871 Year Return
